MIDA Biotech is creating an innovation platform to develop game challenging stem cell therapies.
MIDA Biotech has raised $4.3M in total funding. The most recent round was Grant. The last funding was announced in April 2022.
MIDA Biotech's investors include European Innovation Coouncil Pathfinder.
MIDA Biotech is headquartered in Amsterdam, The Netherlands.
MIDA Biotech is creating an innovation platform to develop game challenging stem cell therapies.
MIDA Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MIDA Biotech — Funding & Investors." VCBacked, April 7, 2022, https://www.vcbacked.co/company/mida-biotech. Accessed September 30, 2026.
VCBacked. (2022). MIDA Biotech — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mida-biotech
{{cite web |title=MIDA Biotech — Funding & Investors |url=https://www.vcbacked.co/company/mida-biotech |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated